FPH.AX
Fisher & Paykel Healthcare Corporation Limited
ASXAUDEQUITY
DELAYED
Last price
36.31
▲ 0.57 (1.59%)
MARKET · —
Price
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
35.89
Prev close
35.74
Day high
36.59
Day low
35.53
Volume
497.60K
Market cap
—
P/E (TTM)
—
52W range
26.51 – 36.59
Trailing performance
Returnvs SPY
1W
+2.69%
+4.1%
1M
+9.96%
+6.2%
3M
+31.89%
+28.8%
6M
+10.33%
-0.7%
YTD
+11.21%
-1.1%
1Y
+7.33%
-12.7%
3Y
+76.69%
+2.5%
5Y
+17.62%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on FPH.AX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.31B | $1.28B | $1.76B | $1.59B | +80.3% |
| Operating revenue | $2.31B | $1.28B | $1.76B | $1.59B | +80.3% |
| Cost of revenue | $838.30M | $750.10M | $698.40M | $642.70M | +11.8% |
| Gross profit | $1.47B | $530.20M | $1.06B | $945.90M | +177.3% |
| Research & development | $235.50M | $226.90M | $198.20M | $174.30M | +3.8% |
| Selling, general & admin | $598.20M | $534.40M | $492.80M | $431.90M | +11.9% |
| Total operating expense | $992.30M | $901.20M | $805.30M | $705.20M | +10.1% |
| Operating income | $477.80M | -$371.00M | $254.40M | $240.70M | +228.8% |
| Net interest income | -$2.10M | -$6.80M | -$14.90M | -$4.10M | +69.1% |
| Pre-tax income | $631.50M | $503.30M | $235.70M | $328.00M | +25.5% |
| Tax provision | $163.00M | $126.10M | $103.10M | $77.70M | +29.3% |
| Net income | $468.50M | $377.20M | $132.60M | $250.30M | +24.2% |
| Net income to common | $468.50M | $377.20M | $132.60M | $250.30M | +24.2% |
| Basic EPS | 0.80 | 0.64 | 0.23 | 0.43 | +23.9% |
| Diluted EPS | 0.79 | 0.64 | 0.23 | 0.43 | +24.1% |
| EBIT | $641.80M | $514.40M | $253.90M | $334.70M | +24.8% |
| EBITDA | $800.40M | $654.30M | $368.20M | $433.70M | +22.3% |
| Basic shares | 586.93M | 585.54M | 581.97M | 578.14M | +0.2% |
| Diluted shares | 590.79M | 590.30M | 586.73M | 582.09M | +0.1% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $461.10M | $264.50M | $82.00M | $121.00M | — | +74.3% |
| Cash & short-term investments | $461.10M | $264.50M | $82.00M | $121.00M | — | +74.3% |
| Accounts receivable | $291.50M | $267.30M | $223.00M | $184.50M | — | +9.1% |
| Inventory | $327.30M | $342.90M | $320.40M | $365.80M | — | -4.5% |
| Total current assets | $1.15B | $935.40M | $704.90M | $774.20M | — | +23.2% |
| Property, plant & equipment | $1.41B | $1.34B | $1.34B | $1.15B | — | +5.1% |
| Goodwill & intangibles | $72.70M | $82.10M | $88.40M | $85.60M | — | -11.4% |
| Total assets | $2.85B | $2.55B | $2.28B | $2.20B | — | +11.9% |
| Total current liabilities | $497.80M | $500.40M | $385.00M | $289.80M | — | -0.5% |
| Current debt | $7.30M | $64.00M | $78.50M | $4.20M | — | -88.6% |
| Long-term debt | $52.50M | — | $35.70M | $79.10M | $63.00M | — |
| Total debt | $146.10M | $153.30M | $189.10M | $145.80M | — | -4.7% |
| Total liabilities | $738.20M | $660.40M | $522.60M | $451.10M | — | +11.8% |
| Retained earnings | $1.44B | $1.23B | $1.09B | $1.20B | — | +17.6% |
| Shareholder equity | $2.12B | $1.89B | $1.76B | $1.75B | — | +11.9% |
| Working capital | $654.40M | $435.00M | $319.90M | $484.40M | — | +50.4% |
| Net tangible assets | $2.04B | $1.81B | $1.67B | $1.67B | — | +13.0% |
| Shares issued | 587.28M | 583.54M | 583.96M | 579.22M | — | +0.6% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Capital expenditure | -$195.20M | -$103.00M | -$339.00M | -$211.30M | -89.5% |
| Investing cash flow | -$195.20M | -$103.00M | -$339.00M | -$11.30M | -89.5% |
| Dividends paid | -$252.30M | -$195.90M | -$145.50M | -$195.70M | -28.8% |
| Financing cash flow | -$276.70M | -$268.20M | -$128.70M | -$197.10M | -3.2% |
| Free cash flow | $468.00M | $445.60M | $90.60M | $26.90M | +5.0% |
| End cash position | $453.80M | $260.20M | $80.90M | $116.80M | +74.4% |
| Line item | 2025-03-31 | YoY |
|---|---|---|
| Total revenue | $1.28B | |
| Operating revenue | $1.28B | |
| Cost of revenue | $750.10M | |
| Gross profit | $530.20M | |
| Research & development | $226.90M | |
| Selling, general & admin | $534.40M | |
| Total operating expense | $901.20M | |
| Operating income | -$371.00M | |
| Net interest income | -$6.80M | |
| Pre-tax income | $503.30M | |
| Tax provision | $126.10M | |
| Net income | $377.20M | |
| Net income to common | $377.20M | |
| Basic EPS | 0.64 | |
| Diluted EPS | 0.64 | |
| EBIT | $514.40M | |
| EBITDA | $654.30M | |
| Basic shares | 585.54M | |
| Diluted shares | 590.30M |
| Line item | 2026-03-31 | 2025-03-31 | YoY |
|---|---|---|---|
| Cash & equivalents | $461.10M | $264.50M | +74.3% |
| Cash & short-term investments | $461.10M | $264.50M | +74.3% |
| Accounts receivable | $291.50M | $267.30M | +9.1% |
| Inventory | $327.30M | $342.90M | -4.5% |
| Total current assets | $1.15B | $935.40M | +23.2% |
| Property, plant & equipment | $1.41B | $1.34B | +5.1% |
| Goodwill & intangibles | $72.70M | $82.10M | -11.4% |
| Total assets | $2.85B | $2.55B | +11.9% |
| Total current liabilities | $497.80M | $500.40M | -0.5% |
| Current debt | $7.30M | $64.00M | -88.6% |
| Long-term debt | $52.50M | — | — |
| Total debt | $146.10M | $153.30M | -4.7% |
| Total liabilities | $738.20M | $660.40M | +11.8% |
| Retained earnings | $1.44B | $1.23B | +17.6% |
| Shareholder equity | $2.12B | $1.89B | +11.9% |
| Working capital | $654.40M | $435.00M | +50.4% |
| Net tangible assets | $2.04B | $1.81B | +13.0% |
| Shares issued | 587.28M | 583.54M | +0.6% |
| Line item | 2025-03-31 | YoY |
|---|---|---|
| Capital expenditure | -$103.00M | |
| Investing cash flow | -$103.00M | |
| Dividends paid | -$195.90M | |
| Financing cash flow | -$268.20M | |
| Free cash flow | $445.60M | |
| End cash position | $260.20M |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
35.41
+2.54% from price
SMA 20
34.96
+3.87% from price
SMA 50
33.40
+8.70% from price
SMA 100
31.70
+14.54% from price
SMA 200
32.18
+12.85% from price
EMA 12
35.32
+2.80% from price
EMA 26
34.62
+4.89% from price
EMA 50
33.65
+7.91% from price
RSI (14)
70.3
Overbought
MACD (12,26,9)
0.70
Hist 0.00
ATR (14)
0.66
1.82% of price
Realised vol 30D
17.2%
Annualised
Bollinger upper
36.44
20, 2σ
Bollinger lower
33.48
20, 2σ
50 / 200 cross
Golden
33.40 vs 32.18
Trend bias
Above 200
+12.85%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.09
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
17.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-23.1%
Peak to trough
Max drawdown 5Y
-50.4%
Peak to trough
ATR 14
0.66
1.82% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Alibaba Group Announced Proposed Placing of New Shares in Hong Kong
Business Wire · 13m ago
Mark Zuckerberg Published a 6,500-Word AI Manifesto This Week Defending Meta's Unrestricted AI Buildout. Here's Why Investors Should Care.
Motley Fool · 23m ago
Encompass Health (EHC) Stock May Be 16% Undervalued As Cash Flow Holds Up
Simply Wall St. · 27m ago
Is HighPeak Energy (HPK) Still Trading At A Discount After Q2?
Simply Wall St. · 28m ago
Unusual Machines (UMAC) Changes Stockholder Voting Rules
Simply Wall St. · 28m ago
Opera (OPRA) Stock Still Looks Reasonable As It Raises 2026 Guidance
Simply Wall St. · 28m ago
Verra Mobility (VRRM) Stock Sees Fair Value Cut After Avis Reset And Analyst Caution
Simply Wall St. · 28m ago
Prairie Operating (PROP) Stock Fair Value Moves Lower After Analysts Cut Targets
Simply Wall St. · 28m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.